PL2938747T3 - Sposób wytwarzania szczepionki przeciwko mykoplazmie - Google Patents

Sposób wytwarzania szczepionki przeciwko mykoplazmie

Info

Publication number: PL2938747T3
Authority: PL; Poland
Prior art keywords: making; mycoplasma vaccine; mycoplasma; vaccine
Prior art date: 2012-12-28

Application number

PL13817835T

Other languages

English (en)

Inventor

Dianna M Murphy Jordan

Brian Thomas Martinson

Christine Margaret Muehlenthaler

Axel Neubauer

Arun V Iyer

Original Assignee

Boehringer Ingelheim Vetmedica Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-28

Filing date

2013-12-20

Publication date

2019-11-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49917778&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2938747(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-12-20 Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh

2019-11-29 Publication of PL2938747T3 publication Critical patent/PL2938747T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/70—Non-animal cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Developmental Biology & Embryology (AREA)
Medicinal Preparation (AREA)

PL13817835T 2012-12-28 2013-12-20 Sposób wytwarzania szczepionki przeciwko mykoplazmie PL2938747T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261746997P	2012-12-28	2012-12-28
EP13817835.5A EP2938747B1 (en)	2012-12-28	2013-12-20	Method of making a mycoplasma vaccine
PCT/US2013/076807 WO2014105672A1 (en)	2012-12-28	2013-12-20	Method of making a mycoplasma vaccine

Publications (1)

Publication Number	Publication Date
PL2938747T3 true PL2938747T3 (pl)	2019-11-29

Family

ID=49917778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13817835T PL2938747T3 (pl)	2012-12-28	2013-12-20	Sposób wytwarzania szczepionki przeciwko mykoplazmie

Country Status (23)

Country	Link
US (2)	US9273281B2 (pl)
EP (1)	EP2938747B1 (pl)
JP (2)	JP6122146B2 (pl)
KR (1)	KR102153275B1 (pl)
CN (2)	CN108379571A (pl)
AR (1)	AR094648A1 (pl)
AU (1)	AU2013370983B2 (pl)
BR (1)	BR112015012711B1 (pl)
CA (1)	CA2896298C (pl)
CL (1)	CL2015001562A1 (pl)
DK (1)	DK2938747T3 (pl)
EA (1)	EA032772B1 (pl)
ES (1)	ES2738100T3 (pl)
HU (1)	HUE045015T2 (pl)
MX (2)	MX361273B (pl)
MY (1)	MY173223A (pl)
PH (1)	PH12015501333B1 (pl)
PL (1)	PL2938747T3 (pl)
PT (1)	PT2938747T (pl)
SG (2)	SG11201505089YA (pl)
TW (2)	TWI618542B (pl)
UA (1)	UA121193C2 (pl)
WO (1)	WO2014105672A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
PT2938747T (pt) *	2012-12-28	2019-08-01	Boehringer Ingelheim Vetmedica Gmbh	Método de preparação de uma vacina de micoplasma
AU2013370982C9 (en) *	2012-12-28	2019-01-24	Boehringer Ingelheim Vetmedica Gmbh	Immunogenic composition comprising mycoplasma antigens
AU2016380864B2 (en)	2015-12-28	2019-10-31	Boehringer Ingelheim Animal Health USA Inc.	M hyo multivalent vaccine and uses thereof
CN105441368B (zh) *	2016-01-19	2019-01-01	福清市默克兽医院	一株牛支原体及其应用
US10222383B2 (en)	2016-01-29	2019-03-05	Advanced Animal Diagnostics, Inc.	Methods and compositions for detecting mycoplasma exposure
AU2017238217A1 (en)	2016-03-22	2018-10-11	Advanced Animal Diagnostics, Inc.	Methods and compositions for reducing antibiotic administration to farm animals
CN109476711B (zh) *	2016-08-09	2023-08-08	财团法人农业科技研究院	防治猪鼻霉浆菌感染的组合物及生产该组合物的方法
US20180221407A1 (en) *	2017-02-03	2018-08-09	The Administrators Of The Tulane Educational Fund	Ophthalmic compositions for therapeutic and prophylactic uses
CN110650989B (zh)	2017-05-24	2023-03-31	三菱化学株式会社	成型材料、及纤维增强复合材料
CN114375326A (zh)	2019-06-10	2022-04-19	礼蓝美国公司	支原体培养基制剂
CN113201050B (zh) *	2020-08-06	2022-07-22	青岛诺安百特生物技术有限公司	一种金黄色葡萄球菌噬菌体穿孔素及其制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2909462A (en)	1955-12-08	1959-10-20	Bristol Myers Co	Acrylic acid polymer laxative compositions
GB1074920A (en) *	1965-04-21	1967-07-05	Pfizer & Co C	Growth medium for mycoplasma pneumoniae and vaccine production
ES343655A1 (es) *	1966-07-11	1968-09-01	Research Corp	Metodo para la preparacion de un inoculo para aves de co- rral.
JPS5540568B2 (pl)	1972-10-05	1980-10-18
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CA2401117C (en) *	2000-03-03	2010-06-29	Juridical Foundation The Chemo-Sero-Therapeutic Research Institute	Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
JP3402304B2 (ja) *	2000-03-30	2003-05-06	株式会社微生物化学研究所	猫クラミジアワクチンの製造方法
MY129765A (en)	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
US7018638B2 (en)	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine
MXPA03011924A (es)	2001-07-02	2004-03-26	Pfizer Prod Inc	Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
US20030147914A1 (en)	2001-07-02	2003-08-07	Pfizer Inc.	Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
JP2005515162A (ja)	2001-07-02	2005-05-26	ファイザー・プロダクツ・インク	マイコプラズマ・ハイオニューモニエ（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）を用いた単回ワクチン接種
BR0211563A (pt)	2001-08-28	2004-07-13	Pfizer Prod Inc	Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão
TWI238721B (en)	2003-06-20	2005-09-01	Animal Technology Inst Taiwan	Swine enzootic vaccine, its producing method and usage
CA2595556A1 (en)	2005-02-09	2006-08-17	Magna International Inc.	Method of manufacturing a semi-structural panel
WO2006095431A1 (ja) *	2005-03-10	2006-09-14	Kyoritsu Seiyaku Corporation	動物由来の成分なしで培養可能である細胞株及びその作出方法、これを用いたウイルスの生産方法、及びワクチンの生産方法
US20090042814A1 (en) *	2005-10-14	2009-02-12	Ivan Petyaev	Treatment and Diagnosis of Obligate Intracellular Pathogens
AU2007347716B2 (en)	2006-09-15	2013-06-20	Medimmune, Llc	MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
US20090068231A1 (en)	2007-09-11	2009-03-12	Wyeth	Live attenuated mycoplasma strains
CL2008003202A1 (es)	2007-10-29	2009-11-27	Boehringer Ingelheim Vetmedica Inc	Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
US9056909B2 (en)	2007-11-06	2015-06-16	Zoetis Services Llc	Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
KR20100113582A (ko)	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US8444989B1 (en)	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
WO2009142086A1 (ja)	2008-05-23	2009-11-26	学校法人久留米大学	マイコプラズマ感染症用ワクチン組成物
ES2569907T3 (es)	2008-06-27	2016-05-13	Zoetis Services Llc	Composiciones adyuvantes novedosas
SG10201506597RA (en)	2008-10-31	2015-10-29	Boehringer Ingelheim Vetmed	Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
PE20120909A1 (es)	2009-05-19	2012-08-19	Bioproperties Pty Ltd	Cepa de vacuna de mycoplasma hyopneumoniae sensible a la temperatura y usos de la misma
WO2011075379A1 (en)	2009-12-18	2011-06-23	Boehringer Ingelheim Vetmedica, Inc.	Multivalent vaccine against porcine teschovirus and other disease causing organisms in swine
US8112663B2 (en)	2010-03-26	2012-02-07	Lsi Corporation	Method to establish redundancy and fault tolerance better than RAID level 6 without using parity
CN102258776B (zh)	2011-07-07	2013-07-10	普莱柯生物工程股份有限公司	猪肺炎支原体、猪鼻支原体二联灭活疫苗及其制备方法
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
AU2013370982C9 (en) *	2012-12-28	2019-01-24	Boehringer Ingelheim Vetmedica Gmbh	Immunogenic composition comprising mycoplasma antigens
PT2938747T (pt)	2012-12-28	2019-08-01	Boehringer Ingelheim Vetmedica Gmbh	Método de preparação de uma vacina de micoplasma

2013
- 2013-12-20 PT PT13817835T patent/PT2938747T/pt unknown
- 2013-12-20 MX MX2015007730A patent/MX361273B/es active IP Right Grant
- 2013-12-20 MY MYPI2015001621A patent/MY173223A/en unknown
- 2013-12-20 MX MX2018014818A patent/MX384875B/es unknown
- 2013-12-20 DK DK13817835.5T patent/DK2938747T3/da active
- 2013-12-20 CN CN201810161003.1A patent/CN108379571A/zh active Pending
- 2013-12-20 UA UAA201507463A patent/UA121193C2/uk unknown
- 2013-12-20 ES ES13817835T patent/ES2738100T3/es active Active
- 2013-12-20 HU HUE13817835 patent/HUE045015T2/hu unknown
- 2013-12-20 KR KR1020157020447A patent/KR102153275B1/ko active Active
- 2013-12-20 PL PL13817835T patent/PL2938747T3/pl unknown
- 2013-12-20 BR BR112015012711-8A patent/BR112015012711B1/pt active IP Right Grant
- 2013-12-20 EA EA201500701A patent/EA032772B1/ru not_active IP Right Cessation
- 2013-12-20 SG SG11201505089YA patent/SG11201505089YA/en unknown
- 2013-12-20 US US14/135,796 patent/US9273281B2/en active Active
- 2013-12-20 WO PCT/US2013/076807 patent/WO2014105672A1/en not_active Ceased
- 2013-12-20 AU AU2013370983A patent/AU2013370983B2/en not_active Ceased
- 2013-12-20 SG SG10201708028VA patent/SG10201708028VA/en unknown
- 2013-12-20 CN CN201380066001.XA patent/CN104968365B/zh active Active
- 2013-12-20 JP JP2015549759A patent/JP6122146B2/ja active Active
- 2013-12-20 EP EP13817835.5A patent/EP2938747B1/en active Active
- 2013-12-20 PH PH1/2015/501333A patent/PH12015501333B1/en unknown
- 2013-12-20 CA CA2896298A patent/CA2896298C/en active Active
- 2013-12-27 TW TW102148875A patent/TWI618542B/zh active
- 2013-12-27 AR ARP130105050A patent/AR094648A1/es unknown
- 2013-12-27 TW TW107103700A patent/TWI660736B/zh active
2015
- 2015-06-05 CL CL2015001562A patent/CL2015001562A1/es unknown
2016
- 2016-01-19 US US15/000,342 patent/US10512680B2/en active Active
2017
- 2017-03-30 JP JP2017067820A patent/JP6449364B2/ja active Active

Also Published As

Publication number	Publication date
ES2738100T3 (es)	2020-01-20
PH12015501333B1 (en)	2022-10-05
US9273281B2 (en)	2016-03-01
DK2938747T3 (da)	2019-08-05
SG11201505089YA (en)	2015-07-30
AR094648A1 (es)	2015-08-19
JP2016508983A (ja)	2016-03-24
JP2017145253A (ja)	2017-08-24
JP6449364B2 (ja)	2019-01-09
HUE045015T2 (hu)	2019-11-28
CL2015001562A1 (es)	2016-06-24
TW201832777A (zh)	2018-09-16
TW201438732A (zh)	2014-10-16
KR20150100920A (ko)	2015-09-02
US20160136254A1 (en)	2016-05-19
BR112015012711A2 (pt)	2017-07-11
WO2014105672A1 (en)	2014-07-03
MY173223A (en)	2020-01-07
EA032772B1 (ru)	2019-07-31
JP6122146B2 (ja)	2017-04-26
TWI618542B (zh)	2018-03-21
CN104968365B (zh)	2018-04-03
MX384875B (es)	2025-03-14
EP2938747A1 (en)	2015-11-04
MX361273B (es)	2018-12-03
TWI660736B (zh)	2019-06-01
EP2938747B1 (en)	2019-05-01
CN108379571A (zh)	2018-08-10
CA2896298A1 (en)	2014-07-03
UA121193C2 (uk)	2020-04-27
MX2015007730A (es)	2015-09-07
AU2013370983B2 (en)	2019-09-26
US20140186394A1 (en)	2014-07-03
BR112015012711B1 (pt)	2022-08-16
PH12015501333A1 (en)	2015-09-02
CA2896298C (en)	2024-01-16
AU2013370983A1 (en)	2015-05-21
US10512680B2 (en)	2019-12-24
EA201500701A1 (ru)	2015-12-30
KR102153275B1 (ko)	2020-09-09
CN104968365A (zh)	2015-10-07
PT2938747T (pt)	2019-08-01
SG10201708028VA (en)	2017-10-30

Publication	Publication Date	Title
SG11201505089YA (en)	2015-07-30	Method of making a mycoplasma vaccine
GB2501785B (en)	2019-04-17	Synchronisation method
IL235890A0 (en)	2015-01-29	vaccine
GB201223032D0 (en)	2013-02-06	Method for forming shaped preform
GB2501243B (en)	2014-06-18	Method of making a medical balloon
GB201223386D0 (en)	2013-02-06	Vaccine
PL2836460T3 (pl)	2022-12-27	Sposób wytwarzania grafenu
GB2508977B (en)	2016-09-07	Method of forming a spoiler
IL234024A0 (en)	2014-09-30	A method for making a multi-layered item
SG11201403957WA (en)	2014-09-26	Kit for producing a vaccine
SG11201504454RA (en)	2015-07-30	A method of vitrification
GB2517862B (en)	2017-03-01	Method of marking a line
PL2931937T3 (pl)	2017-05-31	Sposób wytwarzania układów nanocząstek metali
PL2809816T3 (pl)	2019-04-30	Sposób ekspresji
SG2013017017A (en)	2014-09-26	A method of separation
LU92341B1 (en)	2015-04-29	Method of producing a shaped component
GB201220155D0 (en)	2012-12-26	Method of manufacture
SG11201501567QA (en)	2015-04-29	Method for producing 7-octenal
GB201215942D0 (en)	2012-10-24	Method of treatent
SG2013085071A (en)	2014-07-30	Method of producing methionine
ZA201502028B (en)	2019-09-25	Method of making a panel
PL2662656T3 (pl)	2015-10-30	Sposób wykonania grzejnika
GB201210226D0 (en)	2012-07-25	Vaccine
GB201202090D0 (en)	2012-03-21	Vaccine
GB201219868D0 (en)	2012-12-19	Facilitating completion of a form